GSK Investigational Site

Clydebank G81 4HX

0 studies enrolling now · 4 studies all time

What they study most

Acute Coronary Syndrome, Hypertension, Hypertension, Pulmonary

Studies at this site

• A Study to Evaluate the Safety of 12 Weeks of Dosing With GW856553 and Its Effects on Inflammatory Markers, Infarct Size, and Cardiac Function in Subjects With Myocardial Infarction Without ST-segment Elevation — Completed
• A Study of First-Line Ambrisentan and Tadalafil Combination Therapy in Subjects With Pulmonary Arterial Hypertension (PAH) — Completed
• A Open Label Study to Assess the Long-term Safety, Tolerability and Efficacy of Ambrisentan in Subjects With Inoperable Chronic Thromboembolic Pulmonary Hypertension (CTEPH) — Stopped early
• Ambrisentan for Inoperable Chronic Thromboembolic Pulmonary Hypertension. — Stopped early